Abstract
Tumour treating fields (TTFs) are now FDA approved for high grade glioma treatment. Novel application of this treatment modality is being assessed for paediatric brain tumours and intracranial metastatic disease. Clinical trials are being conducted to test the efficacy of this treatment modality as adjuvant therapy to current standard of care. Here we will discuss the existing literature on TTF its role in pathologies other than GBM. In addition, aspects of safety, compl i ance and cost are al so discussed.
| Original language | English (UK) |
|---|---|
| Pages (from-to) | 1729-1731 |
| Number of pages | 3 |
| Journal | Journal of the Pakistan Medical Association |
| Volume | 68 |
| Issue number | 11 |
| Publication status | Published - Nov 2018 |
Keywords
- Alternating Electric Fields
- Brain Metastasis
- Overall Survival
- Progression Free Survival
- Tumor Treating Fields